Full abstract guidelines will be posted later this year. For a list of previously approved topics see below. These may change slightly for ISTH 2026.

​

Main Topics

• Acquired and Critical Care Bleeding

• Antithrombotic and Fibrinolytic Therapies

• Arterial Disease

• Coagulation Factors and Cofactors

• Coagulation Modifiers, Anticoagulants, and von Willebrand Factor

• Diagnostics, OMICs, and Advanced Technologies

• Fibrinogen, Factor XIII, and Fibrinolysis

• Hemophilia and other Inherited Bleeding Disorders and Inhibitors

• Nurses and Allied Health

• Pediatric Hemostasis and Thrombosis

• Platelet Disorders

• Platelets and Megakaryocytes

• Vascular Biology, Blood Cells, and Immunothrombosis

• Venous Disease

• Women's Hemostasis and Thrombosis

 

Acquired and Critical Care Bleeding

• Antithrombotic Drug-Associated Bleeding

• Coagulopathy of Liver and Renal Disease

• Coagulopathy of Other Systemic Diseases

• Coagulopathy of Trauma

• Massive Transfusion Management

• Perioperative Bleeding

Antithrombotic and Fibrinolytic Therapies

• Current Anticoagulants

• Future Anticoagulants

• Current Antiplatelet Agents

• Future Antiplatelet Agents

• Current and Future Fibrinolytic Therapies

• Antithrombotic Stewardship

Arterial Disease

• Atrial Fibrillation

• Cerebrovascular Disease

• Coronary Artery and Other Cardiac Diseases

• Peripheral Artery Disease

Coagulation Factors and Cofactors

• Common Pathway

• Contact Pathway

• Non-hemostatic Roles of Coagulation Proteins

• Protein Structure and Function

• Synthesis and Biochemistry

• TF and TFPI Pathway

Coagulation Modifiers, Anticoagulants, and von Willebrand Factor

• ADAMTS13 and Other Proteases

• Antithrombin and Other Serpins

• Non-hemostatic Roles of Anticoagulant Proteins

• Protein C/S Pathway

• von Willebrand Factor

Diagnostics, OMICs, and Advanced Technologies

• Artificial Intelligence/Machine Learning

• Genomics and Transcriptomics

• Mathematical and Computational Models

• Novel Experimental Models of Hemostatic and Thrombotic Diseases

• Novel Clinical Laboratory Diagnostic Methods

• Proteomics, Metabolomics, and Lipidomics

Fibrinogen, Factor XIII, and Fibrinolysis

• Factor XIII and Other Transglutaminases

• Fibrinogen Structure and Function

• Fibrinolysis and Proteolysis

Hemophilia and other Inherited Bleeding Disorders and Inhibitors

• Acquired Factor Deficiencies

• Gene Therapy

• Congenital Hemophilia with Inhibitors

• Joint Health

• Novel Hemostatic Therapies

• Rare Factor Deficiencies

• Vascular Disorders

• Von Willebrand Disease

Nurses and Allied Health

• Nurses and Allied Health

Pediatric Hemostasis and Thrombosis

• Bleeding and Thrombotic Issues in Adolescence

• Neonatal Coagulation Disorders

• Pediatric Bleeding and Thrombosis

• Perioperative and Critical Care

Platelet Disorders

• Acquired Platelet Disorders

• Immune Thrombocytopenia - ITP, HIT, PF4 Antibodies

• Inherited Platelet Disorders

• Myeloproliferative Neoplasms and Clonal Disorders

• Thrombotic Microangiopathy

Platelets and Megakaryocytes

• Megakaryocyte Biology

• Non-hemostatic Roles of Platelets

• Platelet Biology

• Receptors and Signaling

Vascular Biology, Blood Cells, and Immunothrombosis

• Blood Vessel Structure and Function

• Coagulation and Cancer

• Coagulation and Non-Malignant Comorbidities

• Endothelial Cell Biology

• Extracellular Vesicles

• Infection and Immunity in Immunothrombosis and Bleeding

• Inflammation and Thrombosis

• Red Cell Disorders and Coagulation

Venous Disease

• Cancer-associated Thrombosis

• Deep and Superficial Venous Thrombosis

• Long-term Consequences of VTE - CTEPH, PTS, etc.

• Pulmonary Embolism

• Thrombophilia

• Unusual Site VTE

Women's Hemostasis and Thrombosis

• Hormonal Modulation of Coagulation

• Menstrual Bleeding Disorders

• Pregnancy

• Hormonal Modulation of Coagulation

• Menstrual Bleeding Disorders

• Pregnancy